Trial NCT04197986

View at ClinicalTrials.gov 
Org. Study IDs: QBGJ398-302
Secondary IDs: 2019-003248-63

Last trial update was posted on 2024-03-13

MeSH Interventions

Infigratinib

MeSH Conditions

Carcinoma Carcinoma, Transitional Cell Urinary Bladder Neoplasms

Other Conditions

Upper Tract Urothelial Carcinomas Urothelial Bladder Cancer

Stopping Reasons

The sponsor has decided to close the study due to the discontinuation of infigratinib development. The discontinuation of the study was not due to safety reasons.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID